within Pharmacolibrary.Drugs.ATC.M;

model M03BX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.34,
    Cl             = 0.00023333333333333333,
    adminDuration  = 600,
    adminMass      = 4 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0024,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.014333333333333333,
    Tlag           = 0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M03BX02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tizanidine is a centrally acting alpha-2 adrenergic agonist used as a muscle relaxant to manage spasticity associated with conditions like multiple sclerosis and spinal cord injury. It is approved for clinical use in various countries, including the US and Europe.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after single oral dose.</p><h4>References</h4><ol><li><p>Pergolizzi, JV, et al., &amp; Varrassi, G (2024). An update on pharmacotherapy for trigeminal neuralgia. <i>Expert review of neurotherapeutics</i> 24(8) 773–786. DOI:<a href=\"https://doi.org/10.1080/14737175.2024.2365946\">10.1080/14737175.2024.2365946</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38870050/\">https://pubmed.ncbi.nlm.nih.gov/38870050</a></p></li><li><p>Zhu, LL, et al., &amp; Zhou, Q (2024). Tizanidine: Advances in Pharmacology &amp; Therapeutics and Drug Formulations. <i>Journal of pain research</i> 17 1257–1271. DOI:<a href=\"https://doi.org/10.2147/JPR.S461032\">10.2147/JPR.S461032</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38529017/\">https://pubmed.ncbi.nlm.nih.gov/38529017</a></p></li><li><p>Mathias, CJ, et al., &amp; Frankel, HL (1989). Pharmacodynamics and pharmacokinetics of the oral antispastic agent tizanidine in patients with spinal cord injury. <i>Journal of rehabilitation research and development</i> 26(4) 9–16. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2600869/\">https://pubmed.ncbi.nlm.nih.gov/2600869</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M03BX02;
